This is a featured company in TheFunded.com Showcase. Members can vote for this company, and, once a quarter, companies with the most votes get invited to an exciting event where they present in front of leading peers, investors, and media in Silicon Valley. Members can also introduce this company to investors they know, as well as provide feedback on the pitch. Enjoy!
BioTech/Health in Ophthalmic Medical Device Sector
Located in New York, US East
CEO is Ted Newill
Offering Launched, < 10 Employees
SRD Vision makes the Salzburg Reading Desk (SRD) that helps eye care professionals more accurately assess reading acuity. The SRD will become an important functional test for patients with presbyopia, macular degeneration and diabetic retinopathy.
$250,000,000 worldwide unconverted market. The market consists of 17,000 Cataract and Refractive Surgeons worldwide; 30,000 Optometrists in the US, Canada & Australia; 5,000 Retinal specialist worldwide and numerous Low Vision clinics.
No direct competition in terms of technology. SRD technology has European patent. We will apply for method patents in the US. Only competition is inefficient and time consuming charts, cards and stopwatches.
Terrific product champions on board.
We plan on starting with key opinion leaders and researchers. 2012 revenue should be $700,000. Then we will move into broader user markets taking advantage of support of KOLs. 2016 revenue will be approx. $5.7 million and 20% EBITDA.
All content provided is for informational purposes only.
This is not an offer to sell securities nor a solicitation of an offer to buy
any securities in the United States of America or any other jurisdiction
where their offer or sale is not permitted.